The House Budget Committee’s recent hearing, “Breaking Up Health Care Monopolies: Examining the Budgetary Effects of Health Care Consolidation,” brought attention to a critical issue facing American consumers: the increasing consolidation within the healthcare industry. Members of Congress highlighted the concerning impact of insurer-pharmacy benefit manager (PBM) conglomerates on patient access to quality care and the growing role of these behemoths in driving up patient costs.